BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2020141)

  • 21. Development of a solid-phase radioimmunoassay for the determination of arginine-vasopressin in urine.
    Larose P; Gutkowska J; du Souich P; Ong H
    J Immunoassay; 1985; 6(3):207-25. PubMed ID: 4044837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassay of arginine vasopressin in the plasma and urine.
    Srámková J; Horký K; Dvoráková J
    Physiol Bohemoslov; 1979; 28(5):399-409. PubMed ID: 160049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A heterologous radioimmunoassay for arginine vasopressin.
    Shimamoto K; Murase T; Yamaji T
    J Lab Clin Med; 1976 Feb; 87(2):338-44. PubMed ID: 1245796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fate of vasopressin perfused into nephrons of Wistar and Brattleboro (diabetes insipidus) rats.
    Lindheimer MD; Reinharz A; Grandchamp A; Vallotton MB
    Clin Sci (Lond); 1980 Feb; 58(2):139-44. PubMed ID: 7357833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of administration of corticotropin-releasing hormone and glucocorticoid on arginine vasopressin response to osmotic stimulus in normal subjects and patients with hypocorticotropinism without overt diabetes insipidus.
    Yamada K; Tamura Y; Yoshida S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):396-401. PubMed ID: 2546964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of vasopressin to produce normal urine concentration in patients with diabetes insipidus.
    ALEXANDER CS; FILBIN DM; FRUCHTMAN SA
    J Lab Clin Med; 1959 Oct; 54():566-71. PubMed ID: 13792580
    [No Abstract]   [Full Text] [Related]  

  • 27. Vasopressin secretion in primary polydipsia and cranial diabetes insipidus.
    Baylis PH; Gaskill MB; Robertson GL
    Q J Med; 1981; 50(199):345-58. PubMed ID: 7036200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sensitive radioimmunoassay for plasma arginine vasopressin (author's transl)].
    Thibonnier M; Soto ME; Marchetti J; Corvol P; Menard J; Milliez P
    Ann Endocrinol (Paris); 1980; 41(5):379-85. PubMed ID: 7235618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma.
    Robertson GL; Mahr EA; Athar S; Sinha T
    J Clin Invest; 1973 Sep; 52(9):2340-52. PubMed ID: 4727463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
    Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK
    J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous urine collection in the study of vasopressin in the newborn.
    Rees L; Brook CG; Forsling ML
    Horm Res; 1983; 17(3):134-40. PubMed ID: 6852776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of arginine vasopressin.
    El-Farhan N; Hampton D; Penney M
    Methods Mol Biol; 2013; 1065():129-39. PubMed ID: 23996361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A simple and highly sensitive radioimmunoassay for 8-arginine vasopressin in human plasma using a reversed-phase C18 silica column].
    Sakurai H; Kurimoto F; Ohono H; Kanai A; Nomura K; Demura H; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1985 Jul; 61(7):724-36. PubMed ID: 2998894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.
    Moses AM; Scheinman SJ; Oppenheim A
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1044-9. PubMed ID: 6490792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary excretion of aquaporin-2 in pathological states of water metabolism.
    Ishikawa S
    Ann Med; 2000 Mar; 32(2):90-3. PubMed ID: 10766399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dilatative uropathy as a manifestation of neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin-II gene.
    Lindenthal V; Mainberger A; Morris-Rosendahl DJ; Löning L; Mayer W; Müller HL
    Klin Padiatr; 2013 Dec; 225(7):407-12. PubMed ID: 24158882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation.
    McLeod JF; Kovács L; Gaskill MB; Rittig S; Bradley GS; Robertson GL
    J Clin Endocrinol Metab; 1993 Sep; 77(3):599A-599G. PubMed ID: 8370682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical physiology of water metabolism. Part II: Renal mechanisms for urinary concentration; diabetes insipidus.
    Weitzman RE; Kleeman CR
    West J Med; 1979 Dec; 131(6):486-515. PubMed ID: 545867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transient polyuria in pregnancy in diabetes insipidus and gestational diabetes].
    Hensen J; Dolz M; Oelkers W
    Med Klin (Munich); 1991 Dec; 86(12):623-8. PubMed ID: 1770904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid-induced central diabetes insipidus in a case of malignant lymphoma.
    Ohta M; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Yamamoto T; Endo K; Narita M; Abe K
    Tohoku J Exp Med; 1991 Apr; 163(4):245-54. PubMed ID: 1882385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.